PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $573,000 | -50.8% | 19,237 | -51.4% | 0.00% | -62.5% |
| Q1 2016 | $1,164,000 | -56.9% | 39,619 | +15.0% | 0.01% | -61.9% |
| Q4 2015 | $2,701,000 | +7.3% | 34,456 | +3.1% | 0.02% | +10.5% |
| Q3 2015 | $2,518,000 | -57.0% | 33,409 | -33.3% | 0.02% | -45.7% |
| Q2 2015 | $5,852,000 | -49.7% | 50,125 | +1.8% | 0.04% | -47.8% |
| Q1 2015 | $11,630,000 | +10.0% | 49,258 | -11.8% | 0.07% | +1.5% |
| Q4 2014 | $10,575,000 | -12.0% | 55,875 | +11.0% | 0.07% | +3.1% |
| Q3 2014 | $12,014,000 | – | 50,360 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |